TPST · Tempest Therapeutics, Inc.
$0.92
+0.01 (+1.58%)
At close · Aug 7
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“our need for additional capital to fund our planned programs and operations and to continue to operate as a going concern”View the 10-Q filed May 14, 2026
Market Cap
$13.36M
Shares
14.81M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$295K
-54.8%
FY2017
Net Income
-$26.26M
+37.2%
FY2025
Gross Margin
-167.8%
+559.3pp
FY2017
Operating Margin
-17154.58%
-4748.4pp
FY2017
Diluted EPS
-$6.33
+67.5%
FY2025
Operating Cash Flow
-$26.82M
+18.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $295K | — | — | — | — | — | — | — | — | $295K | $653K | $277K | — | — | — | |
| $428K | — | — | — | — | — | — | — | — | $790K | $5.4M | $2.25M | — | — | — | |
| -$133K | — | — | — | — | — | — | — | — | -$495K | -$4.75M | -$1.97M | — | — | — | |
| — | — | — | — | — | — | — | — | — | -167.8% | -727.11% | -711.91% | — | — | — | |
| $5.09M | $12.61M | $28.48M | $17.5M | $22.53M | $17.17M | $20.37M | $27.84M | $14.43M | $18.34M | $21.64M | $18.43M | $21.78M | $23.3M | $7.49M | |
| $16.09M | $13.97M | $13.55M | $11.66M | $12.11M | $9.82M | $15.6M | $17.56M | $8.69M | — | — | — | — | $21.99M | $8.66M | |
| $15.85M | — | — | — | — | — | — | — | — | $27.74M | $49.22M | $51.59M | $26.15M | — | — | |
| $919K | — | — | — | — | — | — | — | — | $1.65M | $2.24M | $1.29M | $450K | $324K | $93K | |
| $3.83M | — | — | — | — | — | — | — | — | $4.03M | $5.4M | — | — | — | — | |
| $30.36M | — | — | — | — | — | — | — | — | $50.9M | $81.67M | $72.28M | $47.93M | $45.29M | $16.15M | |
| -$43.36M | -$26.58M | -$42.03M | -$29.16M | -$34.64M | -$26.99M | -$35.97M | -$45.4M | -$26.87M | -$50.61M | -$81.01M | -$72M | -$47.93M | -$45.29M | -$16.15M | |
| — | — | — | — | — | — | — | — | — | -17154.58% | -12406.13% | -25992.42% | — | — | — | |
| -$62.87M | — | — | — | — | — | — | — | — | -$48.96M | -$78.77M | -$70.71M | -$47.48M | -$44.96M | -$16.06M | |
| $46K | $207K | $1.32M | $1.45M | $1.62M | $1.28M | — | — | $134K | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | -$126K | $109K | $19K | |
| $260K | $313K | $183K | -$334K | -$1.07M | -$1.32M | — | — | — | -$36K | -$164K | -$20K | $122K | — | — | |
| -$9000 | — | — | — | — | — | — | — | — | -$1.02M | -$1.54M | -$1.56M | -$1.58M | — | — | |
| -$29.25M | — | — | — | — | — | — | — | — | -$50.91M | -$82.06M | -$73.14M | — | — | — | |
| $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | $67K | $201K | $75K | $0 | $0 | — | |
| -$43.1M | -$26.26M | -$41.84M | -$29.49M | -$35.71M | -$28.3M | -$36.41M | -$44.57M | -$27.19M | -$50.98M | -$82.26M | -$73.22M | -$49.52M | -$45.18M | -$16.13M | |
| — | — | — | — | — | — | — | — | — | -17279.66% | -12597.24% | -26432.85% | — | — | — | |
| — | — | — | — | — | — | — | $0 | $15K | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | -$50.98M | -$82.26M | -$73.22M | -$49.52M | -$45.28M | -$16.24M | |
| — | — | — | — | — | — | -$36.12M | -$44.55M | — | -$50.94M | -$82.15M | -$73.36M | -$49.56M | -$45.17M | -$16.14M | |
| USD/shares | — | -$6.33 | -$19.50 | -$24.83 | -$40.17 | -$97.11 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | -$6.33 | -$19.50 | -$24.83 | -$40.17 | -$97.11 | — | — | — | — | — | — | — | — | — |
| shares | — | 4.15M | 2.15M | 1.19M | 888.38K | 291.56K | 96.73K | 70.29K | 7933.5949 | 182.95K | 164.86K | 138.9K | 116.14K | 42.82K | 19.15K |
| shares | — | 4.15M | 2.15M | 1.19M | 888.38K | 291.56K | 96.73K | 70.29K | 7933.5949 | 182.95K | 164.86K | 138.9K | 116.14K | 42.82K | 19.15K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
EV/EBIT
—
P/E (TTM)
—
Peer median 0.18×
Peer medians compare against the 210 similar-size Biotechnology companies (of 521 listed).